How two CT health practitioners broadened care they offer. Part of finding ‘best possible solutions’
In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...
Bausch: Potential Breakthrough in Depression Treatment to Unlock $3B Opportunity?
Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...
Fierce Pharma3d
Paratek acquires Optinose, rhinosinusitis spray Xhance in deal worth up to $330M
In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...
Hikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...
Endpoints News3d
Paratek boosts com­mer­cial port­fo­lio in move to buy Opti­nose and its nasal spray
Paratek Pharmaceuticals to acquire Optinose and its nasal drug-device Xhance for up to $330M, expanding beyond antibiotics ...
Spring allergy season is around the corner. Here's what you can do to deal with congestion.
The start of spring kicks off a nasal nuisance for many people, but one drug meant to clear congestion has struggled to do ...